Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8595765rdf:typepubmed:Citationlld:pubmed
pubmed-article:8595765lifeskim:mentionsumls-concept:C0004057lld:lifeskim
pubmed-article:8595765lifeskim:mentionsumls-concept:C0022417lld:lifeskim
pubmed-article:8595765lifeskim:mentionsumls-concept:C0040038lld:lifeskim
pubmed-article:8595765lifeskim:mentionsumls-concept:C0003893lld:lifeskim
pubmed-article:8595765lifeskim:mentionsumls-concept:C0043031lld:lifeskim
pubmed-article:8595765lifeskim:mentionsumls-concept:C0439810lld:lifeskim
pubmed-article:8595765pubmed:issue324lld:pubmed
pubmed-article:8595765pubmed:dateCreated1996-4-16lld:pubmed
pubmed-article:8595765pubmed:abstractTextThis study compares the benefits of aspirin and warfarin prophylactic agents for patients with thromboembolic disease after total joint arthroplasty. It is a prospective randomized study of 388 patients having total hip or total knee surgery. All consecutive patients having total hip or total knee surgery were entered into this study and evaluated with preoperative and postoperative ventilation perfusion scans and a postoperative venogram. The aspirin and warfarin treatment groups were compared by size and location of venographically revealed clots and changes in ventilation perfusion scans. The results showed that there was no difference in the size or location of deep venous thrombosis in the aspirin or warfarin treatment groups. The venogram was negative in 44.5% of patients; 28.8% had small ++calf clots, 16% had large calf clots, 3.9% had popliteal clots, and 6.7% had femoral clots. Patients with total knee replacement had a 2.6 times greater incidence of calf deep venous thrombosis than patients with total hip replacement. There was no difference between the aspirin and warfarin groups in the incidence of changes in ventilation perfusion scans (18.9%). There was no difference between the 2 groups in bleeding complications. The results suggest that aspirin and warfarin are equivalent in prophylaxis against thromboembolic disease, as determined by prevention of venographic changes or changes in ventilation perfusion scans.lld:pubmed
pubmed-article:8595765pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8595765pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8595765pubmed:languageenglld:pubmed
pubmed-article:8595765pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8595765pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8595765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8595765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8595765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8595765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8595765pubmed:statusMEDLINElld:pubmed
pubmed-article:8595765pubmed:monthMarlld:pubmed
pubmed-article:8595765pubmed:issn0009-921Xlld:pubmed
pubmed-article:8595765pubmed:authorpubmed-author:SteinbergM...lld:pubmed
pubmed-article:8595765pubmed:authorpubmed-author:KelleyM AMAlld:pubmed
pubmed-article:8595765pubmed:authorpubmed-author:LotkeP APAlld:pubmed
pubmed-article:8595765pubmed:authorpubmed-author:EckerM LMLlld:pubmed
pubmed-article:8595765pubmed:authorpubmed-author:KeenanA MAMlld:pubmed
pubmed-article:8595765pubmed:authorpubmed-author:MeranzeSSlld:pubmed
pubmed-article:8595765pubmed:authorpubmed-author:PalevskyHHlld:pubmed
pubmed-article:8595765pubmed:issnTypePrintlld:pubmed
pubmed-article:8595765pubmed:ownerNLMlld:pubmed
pubmed-article:8595765pubmed:authorsCompleteYlld:pubmed
pubmed-article:8595765pubmed:pagination251-8lld:pubmed
pubmed-article:8595765pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:meshHeadingpubmed-meshheading:8595765-...lld:pubmed
pubmed-article:8595765pubmed:year1996lld:pubmed
pubmed-article:8595765pubmed:articleTitleAspirin and warfarin for thromboembolic disease after total joint arthroplasty.lld:pubmed
pubmed-article:8595765pubmed:affiliationDepartment of Orthopaedic Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.lld:pubmed
pubmed-article:8595765pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8595765pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8595765pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8595765pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8595765pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8595765lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8595765lld:pubmed